Global Natural Killer (NK) Cell Therapeutics Market Growth (Status and Outlook) 2025-2031

October 2025 | 84 pages | ID: G565AF683856EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Natural Killer (NK) Cell Therapeutics market size will reach US$ 340 million by 2031.

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

LPI (LP Information)' newest research report, the “Natural Killer (NK) Cell Therapeutics Industry Forecast” looks at past sales and reviews total world Natural Killer (NK) Cell Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Natural Killer (NK) Cell Therapeutics sales for 2025 through 2031. With Natural Killer (NK) Cell Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer (NK) Cell Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Natural Killer (NK) Cell Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Natural Killer (NK) Cell Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer (NK) Cell Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer (NK) Cell Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer (NK) Cell Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer (NK) Cell Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Segmentation by Application:
  • Cancer
  • Cardiovascular Diseases
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Chipscreen Biosciences
  • Affimed NV
  • Altor BioScience
  • Innate Pharma
  • Takeda
  • Sorrento Therapeutics
  • NantKwest
  • Bristol-Myers Squibb
  • NKT
  • Henry Ford Health Services
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size (2020-2031)
  2.1.2 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Natural Killer (NK) Cell Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Natural Killer (NK) Cell Therapeutics Segment by Type
  2.2.1 Mogamulizumab
  2.2.2 Lorvotuzumab Mertansine
  2.2.3 Others
2.3 Natural Killer (NK) Cell Therapeutics Market Size by Type
  2.3.1 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Natural Killer (NK) Cell Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Cardiovascular Diseases
  2.4.3 Others
2.5 Natural Killer (NK) Cell Therapeutics Market Size by Application
  2.5.1 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2020-2025)

3 NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Natural Killer (NK) Cell Therapeutics Market Size Market Share by Player
  3.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Natural Killer (NK) Cell Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NATURAL KILLER (NK) CELL THERAPEUTICS BY REGION

4.1 Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025)
4.2 Global Natural Killer (NK) Cell Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Natural Killer (NK) Cell Therapeutics Market Size Growth (2020-2025)
4.4 APAC Natural Killer (NK) Cell Therapeutics Market Size Growth (2020-2025)
4.5 Europe Natural Killer (NK) Cell Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025)
5.2 Americas Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025)
5.3 Americas Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025)
6.2 APAC Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025)
6.3 APAC Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET FORECAST

10.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Natural Killer (NK) Cell Therapeutics Forecast
  10.1.3 APAC Natural Killer (NK) Cell Therapeutics Forecast
  10.1.4 Europe Natural Killer (NK) Cell Therapeutics Forecast
  10.1.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Forecast
10.2 Americas Natural Killer (NK) Cell Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Natural Killer (NK) Cell Therapeutics Forecast
  10.2.2 Canada Market Natural Killer (NK) Cell Therapeutics Forecast
  10.2.3 Mexico Market Natural Killer (NK) Cell Therapeutics Forecast
  10.2.4 Brazil Market Natural Killer (NK) Cell Therapeutics Forecast
10.3 APAC Natural Killer (NK) Cell Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Natural Killer (NK) Cell Therapeutics Market Forecast
  10.3.2 Japan Market Natural Killer (NK) Cell Therapeutics Forecast
  10.3.3 Korea Market Natural Killer (NK) Cell Therapeutics Forecast
  10.3.4 Southeast Asia Market Natural Killer (NK) Cell Therapeutics Forecast
  10.3.5 India Market Natural Killer (NK) Cell Therapeutics Forecast
  10.3.6 Australia Market Natural Killer (NK) Cell Therapeutics Forecast
10.4 Europe Natural Killer (NK) Cell Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Natural Killer (NK) Cell Therapeutics Forecast
  10.4.2 France Market Natural Killer (NK) Cell Therapeutics Forecast
  10.4.3 UK Market Natural Killer (NK) Cell Therapeutics Forecast
  10.4.4 Italy Market Natural Killer (NK) Cell Therapeutics Forecast
  10.4.5 Russia Market Natural Killer (NK) Cell Therapeutics Forecast
10.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Natural Killer (NK) Cell Therapeutics Forecast
  10.5.2 South Africa Market Natural Killer (NK) Cell Therapeutics Forecast
  10.5.3 Israel Market Natural Killer (NK) Cell Therapeutics Forecast
  10.5.4 Turkey Market Natural Killer (NK) Cell Therapeutics Forecast
10.6 Global Natural Killer (NK) Cell Therapeutics Forecast by Type (2026-2031)
10.7 Global Natural Killer (NK) Cell Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Natural Killer (NK) Cell Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Chipscreen Biosciences
  11.1.1 Chipscreen Biosciences Company Information
  11.1.2 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offered
  11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Chipscreen Biosciences Main Business Overview
  11.1.5 Chipscreen Biosciences Latest Developments
11.2 Affimed NV
  11.2.1 Affimed NV Company Information
  11.2.2 Affimed NV Natural Killer (NK) Cell Therapeutics Product Offered
  11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Affimed NV Main Business Overview
  11.2.5 Affimed NV Latest Developments
11.3 Altor BioScience
  11.3.1 Altor BioScience Company Information
  11.3.2 Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offered
  11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Altor BioScience Main Business Overview
  11.3.5 Altor BioScience Latest Developments
11.4 Innate Pharma
  11.4.1 Innate Pharma Company Information
  11.4.2 Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offered
  11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Innate Pharma Main Business Overview
  11.4.5 Innate Pharma Latest Developments
11.5 Takeda
  11.5.1 Takeda Company Information
  11.5.2 Takeda Natural Killer (NK) Cell Therapeutics Product Offered
  11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Takeda Main Business Overview
  11.5.5 Takeda Latest Developments
11.6 Sorrento Therapeutics
  11.6.1 Sorrento Therapeutics Company Information
  11.6.2 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offered
  11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sorrento Therapeutics Main Business Overview
  11.6.5 Sorrento Therapeutics Latest Developments
11.7 NantKwest
  11.7.1 NantKwest Company Information
  11.7.2 NantKwest Natural Killer (NK) Cell Therapeutics Product Offered
  11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 NantKwest Main Business Overview
  11.7.5 NantKwest Latest Developments
11.8 Bristol-Myers Squibb
  11.8.1 Bristol-Myers Squibb Company Information
  11.8.2 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offered
  11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Bristol-Myers Squibb Main Business Overview
  11.8.5 Bristol-Myers Squibb Latest Developments
11.9 NKT
  11.9.1 NKT Company Information
  11.9.2 NKT Natural Killer (NK) Cell Therapeutics Product Offered
  11.9.3 NKT Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 NKT Main Business Overview
  11.9.5 NKT Latest Developments
11.10 Henry Ford Health Services
  11.10.1 Henry Ford Health Services Company Information
  11.10.2 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offered
  11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Henry Ford Health Services Main Business Overview
  11.10.5 Henry Ford Health Services Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Natural Killer (NK) Cell Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mogamulizumab
Table 4. Major Players of Lorvotuzumab Mertansine
Table 5. Major Players of Others
Table 6. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Natural Killer (NK) Cell Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Natural Killer (NK) Cell Therapeutics Key Players Head office and Products Offered
Table 15. Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Natural Killer (NK) Cell Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Natural Killer (NK) Cell Therapeutics
Table 40. Key Market Challenges & Risks of Natural Killer (NK) Cell Therapeutics
Table 41. Key Industry Trends of Natural Killer (NK) Cell Therapeutics
Table 42. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Chipscreen Biosciences Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 47. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offered
Table 48. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Chipscreen Biosciences Main Business
Table 50. Chipscreen Biosciences Latest Developments
Table 51. Affimed NV Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 52. Affimed NV Natural Killer (NK) Cell Therapeutics Product Offered
Table 53. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Affimed NV Main Business
Table 55. Affimed NV Latest Developments
Table 56. Altor BioScience Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 57. Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offered
Table 58. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Altor BioScience Main Business
Table 60. Altor BioScience Latest Developments
Table 61. Innate Pharma Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 62. Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offered
Table 63. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Innate Pharma Main Business
Table 65. Innate Pharma Latest Developments
Table 66. Takeda Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 67. Takeda Natural Killer (NK) Cell Therapeutics Product Offered
Table 68. Takeda Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Takeda Main Business
Table 70. Takeda Latest Developments
Table 71. Sorrento Therapeutics Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 72. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offered
Table 73. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Sorrento Therapeutics Main Business
Table 75. Sorrento Therapeutics Latest Developments
Table 76. NantKwest Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 77. NantKwest Natural Killer (NK) Cell Therapeutics Product Offered
Table 78. NantKwest Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. NantKwest Main Business
Table 80. NantKwest Latest Developments
Table 81. Bristol-Myers Squibb Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 82. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offered
Table 83. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Latest Developments
Table 86. NKT Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 87. NKT Natural Killer (NK) Cell Therapeutics Product Offered
Table 88. NKT Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. NKT Main Business
Table 90. NKT Latest Developments
Table 91. Henry Ford Health Services Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 92. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offered
Table 93. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Henry Ford Health Services Main Business
Table 95. Henry Ford Health Services Latest Developments

LIST OF FIGURES

Figure 1. Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Natural Killer (NK) Cell Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Natural Killer (NK) Cell Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Natural Killer (NK) Cell Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type in 2024
Figure 10. Natural Killer (NK) Cell Therapeutics in Cancer
Figure 11. Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2020-2025) & ($ millions)
Figure 12. Natural Killer (NK) Cell Therapeutics in Cardiovascular Diseases
Figure 13. Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2020-2025) & ($ millions)
Figure 14. Natural Killer (NK) Cell Therapeutics in Others
Figure 15. Global Natural Killer (NK) Cell Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Natural Killer (NK) Cell Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Natural Killer (NK) Cell Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Natural Killer (NK) Cell Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Country in 2024
Figure 24. United States Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Natural Killer (NK) Cell Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Natural Killer (NK) Cell Therapeutics Market Size 2026-2031 ($ millions)